Clinical trial
Vancomycin De-escalation Therapy in Patients With Pneumonia and Negative MRSA Nasal Swab
NCT03586362 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vancomycin De-escalation Therapy in Patients With Pneumonia and Negative MRSA Nasal Swab
- Lead sponsor
- CAMC Health System
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 8, 2018
- Completion date
- September 11, 2023
- Enrollment
- 278 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.